Skip to main content
Top
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

Prospective assessment of subjective sleep benefit in Parkinson’s disease

Authors: Merel M van Gilst, Bastiaan R Bloem, Sebastiaan Overeem

Published in: BMC Neurology | Issue 1/2015

Login to get access

Abstract

Background

Parkinson’s disease (PD) patients may experience ‘sleep benefit’ (SB): a temporarily improved mobility upon awakening. SB has mainly been studied retrospectively using questionnaires, but it remains unclear whether it is associated with actual changes in motor functioning.

Methods

We performed a prospective study on sleep-related changes in motor functioning, using a PD symptom diary during 7 days in 240 randomly selected PD patients (140 men; 66.8 ± 9.6 years; disease duration 9.3 ± 6.2 years). Afterwards, patients received a questionnaire on the possible subjective experience of SB.

Results

Using the PD symptom diary, a positive change in motor function was observed after 267 nights (17.8%) and after 138 daytime naps (23.4%). Based on these results, 75 patients (32%) were classified as having SB. In response to the subsequent questionnaire, 73 patients (31%) reported SB. Interestingly, the groups with SB according to either the diary or the questionnaire overlapped only partially: outcomes were congruent in 63% of subjects (both negative 49%, both positive 14%). In both the diary and questionnaire, patients with SB showed a longer disease duration and longer medication use. According to the questionnaire, there was a trend towards a shorter sleep duration and lower sleep efficiency in the SB group. The mean change in motor function after sleep as assessed using the diary was higher in patients reporting subjective SB.

Conclusion

We show that the subjective experience of SB in PD is not always related to an actual increase in reported motor function after sleep. Defining SB using either a symptom diary or a questionnaire on subjective experience, results in only partly overlapping groups. These data suggest that SB may be a more heterogeneous phenomenon than previously thought and that subjective experience of symptom severity is not necessarily related to actual motor function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Comella CL. Sleep disorders in Parkinson’s disease: an overview. Mov Disord. 2007;22 Suppl 17:S367–73.CrossRefPubMed Comella CL. Sleep disorders in Parkinson’s disease: an overview. Mov Disord. 2007;22 Suppl 17:S367–73.CrossRefPubMed
3.
go back to reference Louter M, Aarden WC, Lion J, Bloem BR, Overeem S. Recognition and diagnosis of sleep disorders in Parkinson’s disease. J Neurol. 2012;259(10):2031–40.CrossRefPubMedPubMedCentral Louter M, Aarden WC, Lion J, Bloem BR, Overeem S. Recognition and diagnosis of sleep disorders in Parkinson’s disease. J Neurol. 2012;259(10):2031–40.CrossRefPubMedPubMedCentral
4.
go back to reference Marsden CD. “On-off” phenomena in Parkinson’s disease. In: Rinne U, Klinger M, Stamm G, editors. Parkinson’s Disease: Current Progress, Problems and Management. Amsterdam: Elsevier; 1980. p. 241–54. Marsden CD. “On-off” phenomena in Parkinson’s disease. In: Rinne U, Klinger M, Stamm G, editors. Parkinson’s Disease: Current Progress, Problems and Management. Amsterdam: Elsevier; 1980. p. 241–54.
5.
go back to reference Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson’s disease. Mov Disord. 1997;12(4):506–8.CrossRefPubMed Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson’s disease. Mov Disord. 1997;12(4):506–8.CrossRefPubMed
6.
go back to reference Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord. 1999;14(6):922–7.CrossRefPubMed Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord. 1999;14(6):922–7.CrossRefPubMed
7.
go back to reference Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat Disord. 2004;10(3):157–68.CrossRefPubMed Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat Disord. 2004;10(3):157–68.CrossRefPubMed
8.
go back to reference van Gilst MM, Louter M, Baumann CR, Bloem BR, Overeem S. Sleep benefit in Parkinson’s disease: time to revive an enigma? J Park Dis. 2012;2(2):167–70. van Gilst MM, Louter M, Baumann CR, Bloem BR, Overeem S. Sleep benefit in Parkinson’s disease: time to revive an enigma? J Park Dis. 2012;2(2):167–70.
9.
go back to reference van Gilst MM, Bloem BR, Overeem S. “Sleep benefit” in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(7):654–9.CrossRefPubMed van Gilst MM, Bloem BR, Overeem S. “Sleep benefit” in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(7):654–9.CrossRefPubMed
11.
go back to reference Currie LJ, Bennett Jr JP, Harrison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson’s disease. Neurology. 1997;48(4):1115–7.CrossRefPubMed Currie LJ, Bennett Jr JP, Harrison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson’s disease. Neurology. 1997;48(4):1115–7.CrossRefPubMed
12.
go back to reference Factor SA, Weiner WJ. ‘Sleep benefit’ in Parkinson’s disease. Neurology. 1998;50(5):1514–5.CrossRefPubMed Factor SA, Weiner WJ. ‘Sleep benefit’ in Parkinson’s disease. Neurology. 1998;50(5):1514–5.CrossRefPubMed
13.
go back to reference Högl BE, Gomez-Arevalo G, Garcia S, Scipioni O, Rubio M, Blanco M, et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson’s disease. Neurology. 1998;50(5):1332–9.CrossRefPubMed Högl BE, Gomez-Arevalo G, Garcia S, Scipioni O, Rubio M, Blanco M, et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson’s disease. Neurology. 1998;50(5):1332–9.CrossRefPubMed
14.
go back to reference Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, et al. Activity-based diary for Parkinson’s disease. Clin Neuropharmacol. 2002;25(1):43–50.CrossRefPubMed Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, et al. Activity-based diary for Parkinson’s disease. Clin Neuropharmacol. 2002;25(1):43–50.CrossRefPubMed
15.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed
16.
go back to reference Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed
17.
go back to reference Sherif E, Valko PO, Overeem S, Baumann CR. Sleep benefit in Parkinson’s disease is associated with short sleep times. Parkinsonism Relat Disord. 2014;20(1):116–8.CrossRefPubMed Sherif E, Valko PO, Overeem S, Baumann CR. Sleep benefit in Parkinson’s disease is associated with short sleep times. Parkinsonism Relat Disord. 2014;20(1):116–8.CrossRefPubMed
18.
go back to reference Bolitho SJ, Naismith SL, Salahuddin P, Terpening Z, Grunstein RR, Lewis SJ. Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson’s disease. PLoS One. 2013;8(11):e81233.CrossRefPubMedPubMedCentral Bolitho SJ, Naismith SL, Salahuddin P, Terpening Z, Grunstein RR, Lewis SJ. Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson’s disease. PLoS One. 2013;8(11):e81233.CrossRefPubMedPubMedCentral
19.
go back to reference Aitken D, Naismith SL, Terpening Z, Lewis SJ. Dysfunctional sleep beliefs in Parkinson’s disease: relationships with subjective and objective sleep. J Clin Neurosci. 2014;21(8):1359–63.CrossRefPubMed Aitken D, Naismith SL, Terpening Z, Lewis SJ. Dysfunctional sleep beliefs in Parkinson’s disease: relationships with subjective and objective sleep. J Clin Neurosci. 2014;21(8):1359–63.CrossRefPubMed
Metadata
Title
Prospective assessment of subjective sleep benefit in Parkinson’s disease
Authors
Merel M van Gilst
Bastiaan R Bloem
Sebastiaan Overeem
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-014-0256-2

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue